MedPath

A prospective study of the effect of wound closure on prevention of posterior bleeding for ulcers after endoscopic submucosal dissection (ESD) in patients taking oral antithrombotic medications

Not Applicable
Conditions
Early Stage Gastric Cancer/Gastric Tumor
Registration Number
JPRN-UMIN000053726
Lead Sponsor
agasaki University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients have active multiple cancers. However, intraepithelial or intramucosal carcinoma that can be cured by endoscopic treatment is eligible. (2) The patient has the following serious complications: (i) Serious hepatic disorder Serious hepatic disorder Serious cardiac disease (myocardial infarction, angina pectoris, congestive heart failure, etc.) Serious renal disorder (3) Serious infectious disease. (4) Women who are pregnant or may become pregnant. Women who are lactating. (5) Patients with serious bleeding or in shock. (6) Patients with bleeding tendency. (7) Patients who are currently participating in another clinical trial or for whom at least 3 months have not elapsed since the completion of the trial. (8) Other patients whom the investigators/associate investigators deem inappropriate as subjects.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath